Mid-Year Report

WINNING STRATEGIES WASHINGTON for NOVARTIS

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Agriculture AGR

H.R. 3161; S. 1859-Agriculture Appropriations

LobbyistCovered position, as disclosed
ALEX DELPIZZO N/A
MICHAEL A MEROLA N/A
DONNA MULLINS N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1859 (110th), H.R. 3161 (110th)

Health Issues HCR

Monitor and evaluate all developments on the issue of H.R. 1956; S. 1695-follow-on biologics bill and any related measures including the re-authorization of H.R. 2900; S. 1082-the Prescription Drug User Fee Act (PDUFA) H.R. 3162; S.1893-SCHIP

LobbyistCovered position, as disclosed
ALEX DELPIZZO N/A
MICHAEL A MEROLA N/A
DONNA MULLINS N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1956 (110th), S. 1695 (110th), H.R. 2900 (110th), S. 1082 (110th), H.R. 3162 (110th), S. 1893 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.